Abingworth

Abingworth as of March 31, 2017

Portfolio Holdings for Abingworth

Abingworth holds 17 positions in its portfolio as reported in the March 2017 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Crispr Therapeutics (CRSP) 42.2 $57M 2.6M 21.77
Paratek Pharmaceuticals 18.7 $25M 1.3M 19.25
Sientra 13.8 $18M 2.2M 8.39
Cymabay Therapeutics (CBAY) 5.1 $6.9M 1.6M 4.29
Cascadian Therapeutics 2.9 $3.8M 925k 4.14
Chiasma 2.6 $3.5M 2.1M 1.70
Proteon Therapeutics 2.6 $3.4M 2.0M 1.70
Lombard Med (EVARF) 2.0 $2.7M 3.5M 0.78
Cellectis S A (CLLS) 1.8 $2.4M 100k 24.00
Dermira 1.8 $2.4M 70k 34.09
Immune Design 1.8 $2.4M 352k 6.75
Aurinia Pharmaceuticals (AUPH) 1.4 $1.8M 252k 7.33
Histogenics Corp Cmn 1.1 $1.5M 889k 1.66
Adaptimmune Therapeutics (ADAP) 1.0 $1.4M 250k 5.50
Senseonics Hldgs (SENS) 0.7 $920k 517k 1.78
Innocoll 0.4 $586k 537k 1.09
Novan 0.2 $337k 53k 6.31